Investigating the interrelatedness of clinical and non-clinical parameters affecting outcomes in COVID-19 patients: a retrospective study

被引:0
作者
Asim, Mohammad [1 ]
Rahatullah, Arslan [1 ]
Wahid, Khatira [1 ]
Wahid, Fakhria [1 ,2 ]
机构
[1] North West Gen Hosp & Res Ctr, Dept Med, Peshawar, Pakistan
[2] Natl Univ Sci & Technol NUST, Inst Environm Sci & Engn IESE, Dept Med, Islamabad, Pakistan
关键词
COVID-19; complications; dyspnea; hypertension; demographics; clinical; ACUTE KIDNEY INJURY; ABO BLOOD-GROUP;
D O I
10.1080/20477724.2022.2064796
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The COVID-19 pandemic has affected millions globally. Several studies have been carried out to uncover factors affecting the severity of the resulting infection. Available location-specific data concerning the affective demographics as well as clinical aspect of the disease remains limited. In this study, a number of non-clinical as well as the clinical parameters were investigated for their role in adverse progression of the disease in patients admitted to intensive care unit (ICU) in a private tertiary hospital in Peshawar. The prevalence of comorbidities hypertension and diabetes as well as mortality was higher in age group of 70-79 years. Dyspnea was significantly linked to sepsis, invasive ventilation, and mortality; its late presentation, i.e. 15 to 20 days was significantly associated with mortality (p-value < 0.02). Acute kidney injury and acute respiratory distress syndrome were found to be the most strongly associated with sepsis and septic shock. Neither remdesivir nor tocilizumab was effective in preventing the infection-related complications, invasive ventilation, and mortality. Overall, dyspnea was found to be an indicator of the worst progression of the disease. Furthermore, while some parameters were closely linked, others were not.
引用
收藏
页码:212 / 218
页数:7
相关论文
共 43 条
[1]   Progress of COVID-19 Epidemic in Pakistan [J].
Abid, Khadijah ;
Bari, Yashfika Abdul ;
Younas, Maryam ;
Tahir Javaid, Sehar ;
Imran, Abira .
ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2020, 32 (04) :154-156
[2]  
Alobaidi R, 2015, SEMIN NEPHROL, V35, P2, DOI [10.1016/j.semnephrol.2015.01.002, 10.1016/j.ccc.2020.11.010]
[3]   Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study [J].
Alrashed, Ahmed A. ;
Khan, Tahir M. ;
Alhusseini, Noara K. ;
Asdaq, Syed Mohammed Basheeruddin ;
Enani, Mushira ;
Alosaimi, Bandar ;
Alkhani, Nada M. ;
Mohzari, Yahya ;
Alghalbi, Maram M. ;
Alfahad, Wafa ;
Alanazi, Mona A. ;
Albujaidya, Asma S. ;
Ben-Akresh, Amal ;
Almutairi, Malak ;
Abraham, Ivo ;
Alamer, Ahmad .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (06) :726-733
[4]   Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage [J].
Amor, S. ;
Blanco, L. Fernandez ;
Baker, D. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 202 (02) :193-209
[5]   Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases [J].
Barek, Md. Abdul ;
Aziz, Md. Abdul ;
Islam, Mohammad Safiqul .
HELIYON, 2020, 6 (12)
[6]  
Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]
[7]   Acute kidney injury in sepsis [J].
Bellomo, Rinaldo ;
Kellum, John A. ;
Ronco, Claudio ;
Wald, Ron ;
Martensson, Johan ;
Maiden, Matthew ;
Bagshaw, Sean M. ;
Glassford, Neil J. ;
Lankadeva, Yugeesh ;
Vaara, Suvi T. ;
Schneider, Antoine .
INTENSIVE CARE MEDICINE, 2017, 43 (06) :816-828
[8]  
Caramelo F., 2020, MEDRXIV, DOI [DOI 10.1101/2020.02.24.20027268, 10.1101/2020.02.24.20027268]
[9]  
Chaudhry, 2020, MORTALITY ANAL COVID
[10]  
Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]